Carmine N. Stengone Sells $41.1K of Contineum Therapeutics Inc (CTNM) — SEC Form 4, Sep 08, 2026

Open-Market Net Sale · SEC Form 4

−$41,142

10b5-1 Plan

Reporting Owner

Carmine N. Stengone

CEO

TXN 2026-09-08 · FILED 2026-09-08

Equity Position 19.7K sh 19,717 → 19,717

Filing Lag 0 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Contineum Therapeutics Inc

CTNM CIK 0001855175

Reporting Owner

Name	Relationship
Carmine N. Stengone CIK 0001861519	Director CEO

Carmine N. Stengone at Contineum Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) $401,379

More from this insider at Contineum Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Class A Common StockF1	2026-09-08	M - Exercise 10b5-1	2,500 A	$1.01	+$2,525	19,717	Direct
Class A Common StockF1 F2	2026-09-08	S - Sale 10b5-1	2,500 D	$16.46	-$41,142	17,217	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (right to buy)F1 F3	$1.01	2026-09-08	M - Exercise 10b5-1	2,500 D	$0.00	2030-02-24	2,500 Class A Common Stock	Direct

Footnotes (3)

F1: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025. Show more
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.29 to $16.59, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. Show more
F3: Options granted under the Issuer's 2012 Equity Incentive Plan (the "Plan"). The option is fully vested. Show more

5%+ Holders · 13D/G 8 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Contineum Therapeutics Inc

GET /v1/forms/4/0001628280-26-060962 API docs